Literature DB >> 11223334

Reduced hydrolysis of amelogenin may result in X-linked amelogenesis imperfecta.

W Li1, C W Gibson, W R Abrams, D W Andrews, P K DenBesten.   

Abstract

Amelogenesis imperfecta (AI) is a group of inherited disorders with defective tooth enamel formation caused by various gene mutations. One of the mutations substitutes a cytidine to adenine in exon 6 of the X-chromosomal amelogenin gene, which results in a proline to threonine change in the expressed amelogenin. This transformation is four amino acids N terminal to the proteinase cleavage site in amelogenin for enamel matrix metalloproteinase-20 (MMP-20), also known as enamelysin. MMP-20 effects the release of tyrosine rich amelogenin peptide (TRAP) from amelogenin. This study evaluated the rate MMP-20 hydrolyzes the putative mutated amelogenin cleavage site. The proteolytic site was modeled as a substrate by two synthetic peptides, P1 (SYGYEPMGGWLHHQ) and M1 (SYGYETMGGWLHHQ), selected from residue 36-49 of the amino acid sequence for amelogenin and the respective X-linked amelogenin mutant. Recombinant metalloproteinase-20 (rMMP-20) was used to digest the oligopeptides and the truncated peptides were separated by reversed phase HPLC and identified by mass spectrometry. The results demonstrate that both peptides are cleaved between tryptophan and leucine, matching the TRAP cutting site found in tooth enamel. However, the apparent first order rate of digestion of the mutation containing peptide by rMMP-20 was approximately 25 times slower than that of the non-mutated peptide. This study suggests that the reduced rate of TRAP formation due to a single amino acid substitution may alter enamel formation and consequently result in amelogenesis imperfecta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223334     DOI: 10.1016/s0945-053x(00)00121-9

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  17 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Amelogenins in human developing and mature dental pulp.

Authors:  L Ye; T Q Le; L Zhu; K Butcher; R A Schneider; W Li; P K Den Besten
Journal:  J Dent Res       Date:  2006-09       Impact factor: 6.116

Review 3.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

4.  Mmp-20 and Klk4 cleavage site preferences for amelogenin sequences.

Authors:  T Nagano; A Kakegawa; Y Yamakoshi; S Tsuchiya; J C-C Hu; K Gomi; T Arai; J D Bartlett; J P Simmer
Journal:  J Dent Res       Date:  2009-09       Impact factor: 6.116

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 6.  The molecular etiologies and associated phenotypes of amelogenesis imperfecta.

Authors:  J Timothy Wright
Journal:  Am J Med Genet A       Date:  2006-12-01       Impact factor: 2.802

7.  Biomineralization of a self-assembled-, soft-matrix precursor: Enamel.

Authors:  Malcolm L Snead
Journal:  JOM (1989)       Date:  2015-03-01       Impact factor: 2.471

8.  Comparative properties of recombinant human and bovine matrix metalloproteinase-20.

Authors:  Li Zhu; Katoro Tanimoto; Sarah Robinsin; James Chen; Ewa Witkowska; Steve Hall; Thuan Le; Pamela K Denbesten; Wu Li
Journal:  Arch Oral Biol       Date:  2008-03-11       Impact factor: 2.633

9.  Reduced amelogenin-MMP20 interactions in amelogenesis imperfecta.

Authors:  K Tanimoto; T Le; L Zhu; H E Witkowska; S Robinson; S Hall; P Hwang; P Denbesten; W Li
Journal:  J Dent Res       Date:  2008-05       Impact factor: 6.116

10.  A mutation in the mouse Amelx tri-tyrosyl domain results in impaired secretion of amelogenin and phenocopies human X-linked amelogenesis imperfecta.

Authors:  Martin J Barron; Steven J Brookes; Jennifer Kirkham; Roger C Shore; Charlotte Hunt; Aleksandr Mironov; Nicola J Kingswell; Joanne Maycock; C Adrian Shuttleworth; Michael J Dixon
Journal:  Hum Mol Genet       Date:  2010-01-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.